Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial - Concepedia

Concepedia

Publication | Closed Access

Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial

50

Citations

3

References

2022

Year

Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero, Ariana P. Vargas-Delgado, Juan J. Badimón

Diabetes & Metabolic Syndrome Clinical Research & Reviews

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseInsulin ManagementDiabetesDiabetes MellitusEmpatropism TrialNondiabetic Hfref PatientsMedicine

References

	Year	Citations

Page 1